Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2005Transplantation

Tacrolimus Pharmacogenetics: The CYP3A5*1 Allele Predicts Low Dose-Normalized Tacrolimus Blood Concentrations in Whites and South Asians

View Full Paper
Ask AI
Bookmark
Share

Authors

IMIain MacPheeAstraZeneca (United Kingdom)SFSalim FredericksRoyal College of Surgeons in IrelandMMMaha MohamedDubai Medical College

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

MacPhee et al. (2005) studied this question.

synapsesocial.com/papers/6aa3cce7971540f143c7ff4ehttps://doi.org/10.1097/01.tp.0000151766.73249.12
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Influence of Pharmacogenetics on the Time to Achieve Target Tacrolimus Concentrations after Kidney Transplantation2004 · 258 citations
  2. 2Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and p-glycoprotein correlate with dose requirement2002 · 314 citations
  3. 3The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients2004 · 446 citations
  4. 4Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo2000 · 2,373 citations
  5. 5ABSORPTION PROFILING OF CYCLOSPORINE MICROEMULSION (NEORAL) DURING THE FIRST 2 WEEKS AFTER RENAL TRANSPLANTATION12001 · 141 citations